Viking Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VKTX and other ETFs, options, and stocks.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.

CEO

Brian Lian

CEOBrian Lian

Employees

Employees27

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees27

VKTX Key Statistics

Market cap

4.71B

Market cap4.71B

Price-Earnings ratio

-45.11

Price-Earnings ratio-45.11

Dividend yield

—

Dividend yield—

Average volume

4.56M

Average volume4.56M

High today

$48.27

High today$48.27

Low today

$40.50

Low today$40.50

Open price

$44.40

Open price$44.40

Volume

8.84M

Volume8.84M

52 Week high

$99.41

52 Week high$99.41

52 Week low

$17.23

52 Week low$17.23

Analyst ratings

100%

of 14 ratings

Buy

100%

Hold

Sell

Viking Therapeutics

Why Robinhood?

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Show more

VKTX Key Statistics

Analyst ratings

100%

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.